Navigation Links
Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007
Date:2/29/2008

WARNER CHILCOTT LIMITED

Reconciliation of Net Income / (Loss) to Adjusted EBITDA

(In thousands of U.S. dollars)

(Unaudited)

Quarter Ended Year Ended

Dec-31-07 Dec-31-06 Dec-31-07 Dec-31-06

RECONCILIATION TO ADJUSTED

EBITDA:

Net income / (loss) - GAAP $19,687 $(8,520) $28,875 $(153,510)

+ Interest expense, net 27,284 60,214 117,618 206,994

+ Provision for income taxes 12,195 (19,508) 18,416 (11,147)

+ Stepped up basis of inventory

in cost of sales - - - 1,464

+ Non-operating, sponsors'

management fees in SG&A - - - 31,173

+ Non-cash share-based

compensation expense 1,085 1,711 6,115 17,787

+ Depreciation 2,892 2,171 10,250 7,177

+ Amortization of intangible

assets 56,169 68,300 228,330 253,425

+ R&D milestone expense 500 - 14,500 3,000

+ Accretion on preferred stock

in subsidiary - - - 26,190

+ Litigation settlements - - 26,500 -

Adjusted EBITDA of WCL, as

defined $119,812 $104,368 $450,604 $382,553

+ Expenses of WCL and other 5,637 2,465 10,687 2,769

Adjusted EBITDA of Warner

Chilcott Holdings Company

III, Limited., as defined $125,449 $106,833 $461,291 $385,322

Note: Warner Chilcott Holdings Company III, Limited and certain of its

subsidiaries are parties to our credit agreement and the indenture

govern
'/>"/>

SOURCE Warner Chilcott Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related biology technology :

1. Warner Chilcott Announces Earnings Release Date and Conference Call for Fourth Quarter and Full Year 2007 Financial Results
2. Warner Chilcott and Watson Pharmaceuticals Announce Launch of Tilia(TM) Fe
3. Warner Chilcott Announces Earnings Release Date and Conference Call for Third Quarter 2007 Financial Results
4. Warner Chilcott Announces New Information in USPTO Reexamination of Taclonex Patent
5. Warner Chilcott Announces Receipt of Paragraph IV Certification Notice
6. Cepheid Reports Fourth Quarter and Full Year 2007 Results
7. Strategic Diagnostics Reports Fourth Quarter and Full-Year Financial Results
8. US Oncology Reports Fourth Quarter and Fiscal Year 2007 Results
9. Barr Reports GAAP Earnings of $1.18 Per Share for 2007 and $0.30 Per Share for the Fourth Quarter; Adjusted Earnings Were $3.16 Per Share for 2007 and $0.79 Per Share for the Fourth Quarter
10. Masimo Reports Fourth Quarter 2007 and Full Year 2007 Financial Results
11. eResearchTechnology Reports Fourth Quarter and Full Year 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... , Aug. 4, 2015 /PRNewswire/ -- Sinovac Biotech Ltd. ... products in China , today announced ... the second quarter, ended June 30, 2015, after market ... a conference call on Thursday, August 13, 2015, at ... p.m. China Standard Time) to review the Company,s financial ...
(Date:8/3/2015)... 2015  MiMedx Group, Inc. (NASDAQ: MDXG ), ... and patent-protected processes to develop and market advanced products ... Sports Medicine, Ophthalmic and Dental sectors of healthcare, announced ... Annual Canaccord|Genuity Growth Conference in Boston, ... CEO, William C. Taylor , President and COO, ...
(Date:8/3/2015)...  Aethlon Medical, Inc. (Nasdaq: AEMD ), the ... diseases, today announced that it will host its First ... Thursday, August 13, 2015 at 4:30 p.m. Eastern Time. ... release of fiscal 2016 first quarter results.  A recorded ... hours after the call at the Investor Relations portion ...
(Date:8/3/2015)... Aug. 3, 2015 /PRNewswire/ - RepliCel Life Sciences Inc. (TSX.V: ... on the development of autologous cell therapies, announced today that ... the InvestMNT conference held in Minneapolis, Minnesota ... time. Hall,s presentation will highlight RepliCel,s 18-month milestones including CE ... Europe , clinical data from both RCT-01 (tendon) ...
Breaking Biology Technology:Sinovac to Host Conference Call to Report Second Quarter 2015 Unaudited Financial Results 2MiMedx To Present At 35th Annual Canaccord|Genuity Growth Conference 2Aethlon Medical To Host First Quarter Fiscal 2016 Investor Call on August 13, 2015 2RepliCel Presenting at InvestMNT Investor Conference in Minneapolis 2
... the following Webcast:, What: Neogen Corporation 3rd Quarter ... http://www.videonewswire.com/event.asp?id=46587 , How: Live over the ... above., Contact: ... participate during the live webcast, the call will,be archived on the Web ...
... March 18 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.,(TSX: ONC, ... been,granted U.S. Patent 7,344,711 entitled "Use of Adenoviruses ... claims describe methods of treating,cancer using adenoviruses that ... have an activated Ras pathway., "This patent ...
... In video interviews Said,Darwazah, CEO, and Bassam ... plus what they are expecting from the company,in ... available,now on http://www.cantos.com ., It,s free ... register at, http://www.cantos.com . Cantos.com, the online financial ...
Cached Biology Technology:Oncolytics Biotech Inc. Announces Issuance of 26th U.S. Patent 2
(Date:7/31/2015)... Die 10. internationale Konferenz zu Genomik ... und findet vom 22. bis 25. Oktober 2015 ... Die Konferenz feiert in diesem ... ist die ICG weltweit zu einem der einflussreichsten ... eines der dynamischsten, enthusiastischsten und angenehmsten wissenschaftlichen Zusammentreffen. ...
(Date:7/30/2015)... VIEW, Calif. , July 30, 2015 /PRNewswire/ ... and services for gene function analysis and biomarker ... Guide RNA (sgRNA) Knockout Library targeting all human ... specifically and permanently "knock out" a gene,s function. ... provides a high throughput screening tool so that ...
(Date:7/23/2015)... -- Aware, Inc. (NASDAQ: AWRE ), a leading supplier ... its second quarter ended June 30, 2015.  ... a decrease of 33% compared to $6.8 million in the ... of 2015 was $0.3 million, or $0.01 per diluted share, ... in the same period a year ago.  ...
Breaking Biology News(10 mins):Die 10. internationale Konferenz zu Genomik (ICG-10) beginnt im Oktober 2Die 10. internationale Konferenz zu Genomik (ICG-10) beginnt im Oktober 3CELLECTA, INC. Announces Launch of Human Whole Genome CRISPR Knockout Library 2Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6
... president-elect Harvey Nisenbaum, MD, will present the William J. ... April 3 at the 2009 AIUM Annual Convention in ... 1969 to honor an AIUM member that has significantly ... in their particular field. Alred Kurtz, MD, currently ...
... at the Commerce Department,s National Institute of Standards ... on a process for manufacturing integrated circuits at ... used it to develop a method for engineering ... three-dimensional surfaces. As described in a ...
... ward often say that a difficult labor is a sign ... provides scientific proof that a male baby comes with a ... In a study of 66,000 births, Prof. Marek Glezerman, ... Sackler School of Medicine, Tel Aviv University, together with Dr. ...
Cached Biology News:AIUM presents 2009 William J. Fry Memorial Lecture award 2NIST-Cornell team builds world's first nanofluidic device with complex 3-D surfaces 2NIST-Cornell team builds world's first nanofluidic device with complex 3-D surfaces 3NIST-Cornell team builds world's first nanofluidic device with complex 3-D surfaces 4Men are the weaker sex 2
Anti-CD74 Monoclonal Antibody Description: 200 l Research Focus: cell surface antigens Storage: 4C Shipping Temperature: 4C...
NAP-2 (5C7)...
... advanced RACE (rapid amplification of cDNA ends) ... full-length 5' and 3' cDNA ends. The ... Reverse Transcriptase (RT) for improved amplification of ... complex mRNA. The RNase H portion of ...
The Hybrid Hunter Yeast Two-Hybrid System uses the activation of reporter genes to indicate positive protein-protein interactions. Two reporters are used an auxotrophic marker and lacZ....
Biology Products: